An observational study in Chronic Liver Disease and ACLF, sponsored by Institute of Liver and Biliary Sciences, India. Recruiting at 1 site in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Institute of Liver and Biliary Sciences, India · Observational
Liver transplantation (LT) remains the ultimate option to cure intractable end stage liver disease. Nutritional deficiencies are very common among CLD patients and due to this these patients suffer from low bone mineral density leading to osteoporosis and osteopenia. It has been observed that there is substantial reduction in bone density , especially within the first year of LT. The incidence of fractures among LT recipients has been reported to be around 3.5% with vertebral spine being the most common site. Multiple risk factors for osteoporosis after LT has been identified. Some of these include female sex, DM, sedentary lifestyle, pretransplant hypogonadism, Vit-D deficiency and pre-existing bone mineral abnormalities. Patients with CLD are also reported as having osteoblastic dysfunction by many factors, like unconjugated hyperbilirubinemia, decreased synthesis of collagen matrix, and decreased availability of insulin like growth factors. Post-transplant factors among LT recipients include: choice of immunosuppressive therapy like Glucocorticoid and CNIs therapy.
This Observational study aims to analyze the changes in bone mineral metabolism After Liver Transplantation by Bone Mineral Densitometry preoperatively and postoperatively. All eligible adult patients with Chronic Liver Disease undergoing Liver Transplant during the study period will be included in the study. These patients bone mineral density will be assessed using DEXA scan both preop and on Post op at 3 and 6 months. The association between the changes in BMM and various variables such as the sex of the patients, age of patients, etiology of CLD, presence of hepatocellular carcinoma (HCC), ICU stay, Hospital stay will be studied.
Pre-operative, intra-operative and post-operative data will be collected from medical records, electronic hospital information system (HIS) and radiological images collected from the hospital Picture archiving and communication system(PACS). The enrolled subjects will be followed up till for a period of 6 months after the Liver Transplant and the bone mineral density will be compared between these patients along with other parameters.
Institute of Liver and Biliary Sciences, India is the lead sponsor of 296 studies on the registry; 84 are open to participants now.
Counted across the registry records on this site, refreshed daily.
all CLD and ACLF patients irrespective of etiology undergoing living donor liver transplant
- All adult patients >18 yrs with Cirrhosis of Liver undergoing Live Donor Liver Transplant
Exclusion Criteria:
All chronic liver disease undergoing living donor liver transplant.
Other: no intervention
All acute on chronic liver failure patients undergoing living donor liver transplant.
Other: no intervention
No intervention as this is an observational study
assessment of changes in bone mineral mass (BMM) after living donor liver transplant
Time frame: preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and gender
Time frame: preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and age of patients
Time frame: preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and presence of hepatocellular carcinoma (HCC)
Time frame: preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM and etiology
Time frame: preoperative and at 3 months and 6 months post LDLT
evaluate the association between the changes in BMM with ICU stay and Hospital stay
Time frame: preoperative and at 3 months and 6 months post LDLT
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institute of Liver and Biliary Sciences, India